Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
by
Cravatt, Benjamin F
, Niessen, Sherry
, Whiteley, Laurence O
, Roberts, Lee R
, Wang, Chu
, Schnute, Mark E
, Hett, Erik C
, Wei, Baoxian
, Hulce, Jonathan J
, Hayward, Matthew M
, Whitby, Landon R
, Joslyn, Chris
, Douhan, John
, Johnson, Theodore O
, Kath, John C
, Lanning, Bryan R
, Dix, Melissa M
, Gilbert, Adam M
in
631/67
/ 631/92/275
/ 631/92/475
/ 631/92/613
/ 82
/ 82/58
/ Adenine - analogs & derivatives
/ Agammaglobulinaemia Tyrosine Kinase
/ Biochemical Engineering
/ Biochemistry
/ Biology
/ Bioorganic Chemistry
/ Cell Biology
/ Cell Line, Tumor
/ Cell Survival - drug effects
/ Chemistry
/ Chemistry/Food Science
/ Cysteine - chemistry
/ Genes, erbB-1 - genetics
/ Humans
/ Inhibitors
/ Kinases
/ Kinetics
/ Labeling
/ Pharmaceutical sciences
/ Physiology
/ Piperidines
/ Probes
/ Protein Kinase Inhibitors - pharmacology
/ Protein Kinases - metabolism
/ Protein-Tyrosine Kinases - antagonists & inhibitors
/ Proteins
/ Proteome - genetics
/ Pyrazoles - pharmacology
/ Pyrimidines - pharmacology
/ R&D
/ Research & development
/ Roads
/ Signal transduction
/ Signal Transduction - drug effects
/ Signal Transduction - genetics
2014
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
by
Cravatt, Benjamin F
, Niessen, Sherry
, Whiteley, Laurence O
, Roberts, Lee R
, Wang, Chu
, Schnute, Mark E
, Hett, Erik C
, Wei, Baoxian
, Hulce, Jonathan J
, Hayward, Matthew M
, Whitby, Landon R
, Joslyn, Chris
, Douhan, John
, Johnson, Theodore O
, Kath, John C
, Lanning, Bryan R
, Dix, Melissa M
, Gilbert, Adam M
in
631/67
/ 631/92/275
/ 631/92/475
/ 631/92/613
/ 82
/ 82/58
/ Adenine - analogs & derivatives
/ Agammaglobulinaemia Tyrosine Kinase
/ Biochemical Engineering
/ Biochemistry
/ Biology
/ Bioorganic Chemistry
/ Cell Biology
/ Cell Line, Tumor
/ Cell Survival - drug effects
/ Chemistry
/ Chemistry/Food Science
/ Cysteine - chemistry
/ Genes, erbB-1 - genetics
/ Humans
/ Inhibitors
/ Kinases
/ Kinetics
/ Labeling
/ Pharmaceutical sciences
/ Physiology
/ Piperidines
/ Probes
/ Protein Kinase Inhibitors - pharmacology
/ Protein Kinases - metabolism
/ Protein-Tyrosine Kinases - antagonists & inhibitors
/ Proteins
/ Proteome - genetics
/ Pyrazoles - pharmacology
/ Pyrimidines - pharmacology
/ R&D
/ Research & development
/ Roads
/ Signal transduction
/ Signal Transduction - drug effects
/ Signal Transduction - genetics
2014
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
by
Cravatt, Benjamin F
, Niessen, Sherry
, Whiteley, Laurence O
, Roberts, Lee R
, Wang, Chu
, Schnute, Mark E
, Hett, Erik C
, Wei, Baoxian
, Hulce, Jonathan J
, Hayward, Matthew M
, Whitby, Landon R
, Joslyn, Chris
, Douhan, John
, Johnson, Theodore O
, Kath, John C
, Lanning, Bryan R
, Dix, Melissa M
, Gilbert, Adam M
in
631/67
/ 631/92/275
/ 631/92/475
/ 631/92/613
/ 82
/ 82/58
/ Adenine - analogs & derivatives
/ Agammaglobulinaemia Tyrosine Kinase
/ Biochemical Engineering
/ Biochemistry
/ Biology
/ Bioorganic Chemistry
/ Cell Biology
/ Cell Line, Tumor
/ Cell Survival - drug effects
/ Chemistry
/ Chemistry/Food Science
/ Cysteine - chemistry
/ Genes, erbB-1 - genetics
/ Humans
/ Inhibitors
/ Kinases
/ Kinetics
/ Labeling
/ Pharmaceutical sciences
/ Physiology
/ Piperidines
/ Probes
/ Protein Kinase Inhibitors - pharmacology
/ Protein Kinases - metabolism
/ Protein-Tyrosine Kinases - antagonists & inhibitors
/ Proteins
/ Proteome - genetics
/ Pyrazoles - pharmacology
/ Pyrimidines - pharmacology
/ R&D
/ Research & development
/ Roads
/ Signal transduction
/ Signal Transduction - drug effects
/ Signal Transduction - genetics
2014
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Journal Article
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
2014
Request Book From Autostore
and Choose the Collection Method
Overview
ABPP combined with quantitative MS enabled identification of specific on- and off-targets of covalent kinase inhibitors. Modifications to inhibitors that alter specificity beyond a defined window can promote kinase-independent toxicity.
Kinases are principal components of signal transduction pathways and the focus of intense basic and drug discovery research. Irreversible inhibitors that covalently modify non-catalytic cysteines in kinase active sites have emerged as valuable probes and approved drugs. Many protein classes, however, have functional cysteines, and therefore understanding the proteome-wide selectivity of covalent kinase inhibitors is imperative. Here, we accomplish this objective using activity-based protein profiling coupled with quantitative MS to globally map the targets, both specific and nonspecific, of covalent kinase inhibitors in human cells. Many of the specific off-targets represent nonkinase proteins that, notably, have conserved active site cysteines. We define windows of selectivity for covalent kinase inhibitors and show that, when these windows are exceeded, rampant proteome-wide reactivity and kinase target–independent cell death conjointly occur. Our findings, taken together, provide an experimental road map to illuminate opportunities and surmount challenges for the development of covalent kinase inhibitors.
Publisher
Nature Publishing Group US,Nature Publishing Group
Subject
/ 82
/ 82/58
/ Adenine - analogs & derivatives
/ Agammaglobulinaemia Tyrosine Kinase
/ Biology
/ Cell Survival - drug effects
/ Humans
/ Kinases
/ Kinetics
/ Labeling
/ Probes
/ Protein Kinase Inhibitors - pharmacology
/ Protein Kinases - metabolism
/ Protein-Tyrosine Kinases - antagonists & inhibitors
/ Proteins
/ R&D
/ Roads
This website uses cookies to ensure you get the best experience on our website.